P. Chandrasekar

发表

Organism-Dependent Fungicidal Activities of Azoles

E. Manavathu, J. Cutright, P. Chandrasekar, 1998, Antimicrobial Agents and Chemotherapy.

A comparative study of the post-antifungal effect (PAFE) of amphotericin B, triazoles and echinocandins on Aspergillus fumigatus and Candida albicans.

E. Manavathu, P. Chandrasekar, M. Ramesh, 2004, The Journal of antimicrobial chemotherapy.

Appropriate use of polymerase chain reaction for detection of herpes simplex virus 2 in cerebrospinal fluid of patients at an inner-city hospital.

G. Alangaden, P. Chandrasekar, N. Afonso, 2007, Diagnostic microbiology and infectious disease.

Voriconazole: A second-generation triazole.

E. Manavathu, P. Chandrasekar, 2001, Drugs of today.

Diagnostic challenges and recent advances in the early management of invasive fungal infections

P. Chandrasekar, 2010, European journal of haematology.

Clinical issues of blood cultures.

P. Chandrasekar, W. J. Brown, W. Brown, 1994, Archives of internal medicine.

Bone and joint infections in injection drug users.

P. Chandrasekar, V. Kak, 2002, Infectious disease clinics of North America.

Safety of posaconazole

P. Jacinto, P. Chandrasekar, 2013, Expert opinion on drug safety.

Itraconazole and hydroxyitraconazole serum concentrations are reduced more than tenfold by phenytoin

R. Slaughter, G. Mannens, P. Chandrasekar, 1995, Clinical pharmacology and therapeutics.

Safety of triazole antifungal drugs in patients with cancer.

P. Chandrasekar, S. Cronin, 2010, The Journal of antimicrobial chemotherapy.

B iches Usher Dilemmas : Antifungal Therapy in nvasive Aspergillosis

P. Chandrasekar, 2005 .

Riches usher dilemmas: antifungal therapy in invasive aspergillosis.

P. Chandrasekar, 2005, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Nephrotoxicity of vancomycin, alone and with an aminoglycoside.

M. Rybak, P. Chandrasekar, S. Boike, 1990, The Journal of antimicrobial chemotherapy.

Resistance to amphotericin B does not emerge during treatment for invasive aspergillosis.

G. Alangaden, E. Manavathu, P. Chandrasekar, 2002, The Journal of antimicrobial chemotherapy.

Case 12-2013: a woman with pulmonary infiltrates and respiratory failure.

P. Chandrasekar, Pranatharthi H Chandrasekar, 2013, The New England journal of medicine.

Fever of Unknown Origin: An Evidence-Based Review

P. Chandrasekar, K. Hayakawa, B. Ramasamy, 2012, The American journal of the medical sciences.

Gradually Worsening Tattoo Lesion.

P. Chandrasekar, A. Bhargava, 2015, JAMA.

Hemophagocytic lymphohistiocytosis (HLH): Elusive diagnosis of disseminated Mycobacterium avium complex infection.

P. Chandrasekar, E. Ordaya, Sulieman Abu Jarir, 2017, Germs.

Risk Factors and Outcomes Associated With Nocardia Bacteremia

S. Szpunar, P. Jacinto, P. Chandrasekar, 2015 .

The clinical spectrum of pulmonary aspergillosis.

A. Soubani, P. Chandrasekar, 2002, Chest.

Successful therapy with Ledipasvir/Sofosbuvir for hepatitis C reactivation in a hematopoietic stem cell transplant recipient

P. Chandrasekar, Malini Surapaneni, Marian R Wahba, 2016, Leukemia & lymphoma.

Recognition of Misdiagnosed Tuberculosis in a Bone Marrow Transplant Recipient Leads to Identification of "Pseudotuberculosis" Due to Laboratory Contamination

G. Alangaden, P. Chandrasekar, W. J. Brown, 2004 .

Antifungal drugs: predicting clinical efficacy with pharmacodynamics

P. Chandrasekar, M. Nailor, 2009, Expert review of clinical pharmacology.

Failure to obtain microbiological culture and its consequence in a mesh-related infection

D. Paull, P. Chandrasekar, S. Laker, 2013, BMJ Case Reports.

Cervical Adenitis Due to Mycobacterium fortuitum in a Patient with AIDS

G. Alangaden, P. Chandrasekar, J. Samuel, 2000 .

In-vitro and in-vivo susceptibility of Aspergillus fumigatus to a novel conjugated styryl ketone.

J. Dimmock, E. Manavathu, J. Cutright, 1998, The Journal of antimicrobial chemotherapy.

SARS-CoV-2 Viral Load and Myocardial Injury: Independent and Incremental Predictors of Adverse Outcome

A. Abidov, A. Briasoulis, L. Afonso, 2021, Mayo Clinic Proceedings: Innovations, Quality & Outcomes.

A double-blind, randomized, controlled trial of amphotericin B colloidal dispersion versus amphotericin B for treatment of invasive aspergillosis in immunocompromised patients.

J. Wingard, P. Chandrasekar, M. Laverdière, 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Bad news to worse news: 2015 infectious diseases fellowship match results.

P. Chandrasekar, 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Infectious Diseases Subspecialty: Declining Demand Challenges and Opportunities

P. Chandrasekar, L. Johnson, D. Havlichek, 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Prophylaxis against hepatitis B reactivation among patients with lymphoma receiving rituximab

P. Chandrasekar, J. A. Buensalido, 2014, Expert review of anti-infective therapy.

Adherence to hepatitis B screening and prophylactic lamivudine for prevention of rituximab-associated hepatitis B reactivation

C. Schiffer, P. Chandrasekar, P. Chandrasekar, 2013, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

Aspergillus flavus: an emerging non‐fumigatus Aspergillus species of significance

E. Manavathu, P. Chandrasekar, S. Krishnan, 2009, Mycoses.

How Clean Is the Linen at My Hospital? The Mucorales on Unclean Linen Discovery Study of Large United States Transplant and Cancer Centers

J. Perfect, J. Wingard, K. Hanson, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

In-vitro activity of nikkomycin Z alone and in combination with polyenes, triazoles or echinocandins against Aspergillus fumigatus.

G. Alangaden, E. Manavathu, J. Cutright, 2004, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

In vitro interaction of posaconazole with calcineurin inhibitors and sirolimus against zygomycetes.

G. Alangaden, E. Manavathu, P. Chandrasekar, 2010, The Journal of antimicrobial chemotherapy.

Proton-Pumping-ATPase-Targeted Antifungal Activity of a Novel Conjugated Styryl Ketone

J. Dimmock, E. Manavathu, P. Chandrasekar, 1999, Antimicrobial Agents and Chemotherapy.

Clostridium difficile infection in cancer patients and hematopoietic stem cell transplant recipients

G. Alangaden, P. Chandrasekar, T. Chopra, 2010, Expert review of anti-infective therapy.

Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease.

J. Lipton, H. Greinix, D. Vesole, 2007, The New England journal of medicine.

Preventing Varicella-Zoster: Advances With the Recombinant Zoster Vaccine

P. Chandrasekar, Sahrish Ilyas, 2020, Open forum infectious diseases.

Drug-Induced Nephrotoxicity Caused by Amphotericin B Lipid Complex and Liposomal Amphotericin B: A Review and Meta-Analysis

J. Wingard, D. Kontoyiannis, T. Walsh, 2010, Medicine.

Amphotericin B lipid complex in the management of invasive aspergillosis in immunocompromised patients.

J. Ito, P. Chandrasekar, 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Polymicrobial candidemia.

G. Alangaden, P. Chandrasekar, L. Ganesan, 2002, Diagnostic microbiology and infectious disease.

Efficacy and safety of Isavuconazole for the treatment of invasive Aspergillus infection - an update of the literature

P. Chandrasekar, G. Sivasubramanian, 2022, Expert opinion on pharmacotherapy.

Isavuconazole for the treatment of invasive aspergillosis and mucormycosis: current evidence, safety, efficacy, and clinical recommendations

P. Chandrasekar, S. Natesan, S. Krishnan, 2016, Infection and drug resistance.

Infections in Liver, Kidney, Pancreas, and Intestinal Transplant Recipients

B. Suh, A. Truant, G. Alangaden, 2013 .

A comparative study of fungicidal activities of voriconazole and amphotericin B against hyphae of Aspergillus fumigatus.

E. Manavathu, P. Chandrasekar, S. Krishnan, 2005, The Journal of antimicrobial chemotherapy.

Cytomegalovirus infection in autologous stem cell transplant recipients in the era of rituximab

A. Deol, A. Kotecha, P. Chandrasekar, 2016, Annals of Hematology.

Occult hepatitis B virus reactivation in a seronegative stem cell transplant recipient

P. Chandrasekar, Miriam T. Levine, 2017 .

Candida auris: a worrisome, globally emerging pathogen

P. Chandrasekar, S. Revankar, B. Navalkele, 2017, Expert review of anti-infective therapy.

A comparative study of the in vitro susceptibilities of clinical and laboratory-selected resistant isolates of Aspergillus spp. to amphotericin B, itraconazole, voriconazole and posaconazole (SCH 56592).

D. Loebenberg, E. Manavathu, J. Cutright, 2000, The Journal of antimicrobial chemotherapy.

Evaluation of Susceptibility and Innate Immune Response in C57BL/6 and BALB/c Mice During Candida albicans Endophthalmitis

P. Singh, Sneha Singh, P. Chandrasekar, 2020, Investigative ophthalmology & visual science.

Selection criteria for antifungals: the right patients and the right reasons.

P. Chandrasekar, 2006, International journal of antimicrobial agents.

Novel effect of voriconazole on conidiation of Aspergillus species.

G. Alangaden, E. Manavathu, P. Chandrasekar, 2004, International journal of antimicrobial agents.

The effect of fluconazole prophylaxis on fungal colonization in neutropenic cancer patients. Bone Marrow Transplantation Team.

P. Chandrasekar, P. Chandrasekar, C. M. Gatny, 1994, The Journal of antimicrobial chemotherapy.

Current and Future Therapeutic Options in the Management of Invasive Aspergillosis

P. Chandrasekar, S. Krishnan-Natesan, 2012, Drugs.

Tuberculosis in the 1990s: current implications for dentistry.

P. Chandrasekar, J. Cottone, J. Molinari, 1993, Compendium.

Serratia marcescens Infection-Associated Loss of Vision: A Case Report in a Patient with a History of Intravenous Drug Use

P. Chandrasekar, Shirisha Pasula, Vichar Trivedi, 2021, The American journal of case reports.

Contrasting effects of fluconazole and ketoconazole on phenytoin and testosterone disposition in man.

M. Milad, P. Chandrasekar, D. Edwards, 1992, British journal of clinical pharmacology.

Aspergillus Endophthalmitis: Epidemiology, Pathobiology, and Current Treatments

P. Chandrasekar, Ashok Kumar, Susmita Das, 2022, Journal of fungi.

Efficacy of micafungin for the treatment of invasive candidiasis and candidaemia in patients with neutropenia

B. Sirohi, N. Seibel, P. Chandrasekar, 2018, Mycoses.

Phase 3 pharmacokinetics and safety study of a posaconazole tablet formulation in patients at risk for invasive fungal disease

H. Waskin, A. Langston, I. Raad, 2016, The Journal of antimicrobial chemotherapy.

Phase 3 pharmacokinetics and safety study of a posaconazole tablet formulation in patients at risk for invasive fungal disease.

H. Waskin, A. Langston, I. Raad, 2016, The Journal of antimicrobial chemotherapy.

Low infectious morbidity after intensive chemotherapy and autologous peripheral blood progenitor cell transplantation in the outpatient setting for women with breast cancer.

G. Alangaden, G. Chalasani, P. Chandrasekar, 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Duration of Symptoms and Plasma Cytokine Levels in Patients with the Common Cold Treated with Zinc Acetate

B. Bao, F. Beck, A. Prasad, 2000, Annals of Internal Medicine.

Azole resistance in Aspergillus species: promising therapeutic options

P. Chandrasekar, Shirisha Pasula, 2021, Expert opinion on pharmacotherapy.

Isolation and in vitro susceptibility to amphotericin B, itraconazole and posaconazole of voriconazole-resistant laboratory isolates of Aspergillus fumigatus.

E. Manavathu, P. Chandrasekar, O. C. Abraham, 2001, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Reduced susceptibility in laboratory-selected mutants of Aspergillus fumigatus to itraconazole due to decreased intracellular accumulation of the antifungal agent.

J. Vazquez, E. Manavathu, P. Chandrasekar, 1999, International journal of antimicrobial agents.

West Nile virus encephalitis: an emerging disease in renal transplant recipients

S. Gruber, G. Alangaden, P. Chandrasekar, 2004, Clinical transplantation.

Sirolimus exposure during the early post‐transplant period reduces the risk of CMV infection relative to tacrolimus in renal allograft recipients

S. Gruber, G. Alangaden, M. Doshi, 2007, Clinical transplantation.

Spontaneous Hemoptysis in a Patient With COVID-19

P. Chandrasekar, Shirisha Pasula, 2021, Chest.

In-vitro isolation and antifungal susceptibility of amphotericin B-resistant mutants of Aspergillus fumigatus.

G. Alangaden, E. Manavathu, P. Chandrasekar, 1998, The Journal of antimicrobial chemotherapy.

Comparative Study of Susceptibilities of Germinated and Ungerminated Conidia of Aspergillus fumigatus to Various Antifungal Agents

E. Manavathu, J. Cutright, P. Chandrasekar, 1999, Journal of Clinical Microbiology.

Effect of fluconazole prophylaxis on fever and use of amphotericin in neutropenic cancer patients. Bone Marrow Transplantation Team.

P. Chandrasekar, C. M. Gatny, 1994, Chemotherapy.

Invasive mold infections: recent advances in management approaches

P. Chandrasekar, 2009, Leukemia & lymphoma.

Antifungal Therapy Strategies in Hematopoietic Stem-Cell Transplant Recipients: Early Treatment Options for Improving Outcomes

P. Ljungman, P. Chandrasekar, 2008, Transplantation.

Pathobiology of Aspergillus Fumigatus Endophthalmitis in Immunocompetent and Immunocompromised Mice

P. Singh, P. Chandrasekar, S. Revankar, 2019, Microorganisms.

An Appraisal of the Current Guidelines for the Use of Antifungals in the Treatment of Invasive Candidiasis, Aspergillosis, and Mucormycosis

P. Chandrasekar, S. Natesan, 2019 .

Aspergillosis: The most common community-acquired pneumonia with gram-negative Bacilli as copathogens in stem cell transplant recipients with graft-versus-host disease.

M. Wahiduzzaman, G. Alangaden, P. Chandrasekar, 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Antifungal resistance in Aspergillus.

P. Chandrasekar, 2005, Medical mycology.

Prophylaxis Versus a Preemptive Approach for Invasive Aspergillosis

P. Chandrasekar, 2010 .

Recurrent Strongyloides stercoralis hyperinfection syndrome: Case report and a brief review

G. Barger, P. Chandrasekar, S. Krishnan, 2006 .

Effectiveness of cefotaxime in gram-negative meningitis.

J. Lefrock, K. Rolston, P. Chandrasekar, 1984, Neurosurgery.

Micafungin: a new echinocandin.

J. Sobel, P. Chandrasekar, J D Sobel, 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis.

Richard Sylvester, Raoul Herbrecht, John E Bennett, 2002, The New England journal of medicine.

Pharmacokinetics of Oral Posaconazole in Allogeneic Hematopoietic Stem Cell Transplant Recipients with Graft‐versus‐Host Disease

P. Chandrasekar, A. Ullmann, G. Krishna, 2007, Pharmacotherapy.

Effect of zinc supplementation on incidence of infections and hospital admissions in sickle cell disease (SCD)

F. Beck, P. Swerdlow, J. Fitzgerald, 1999, American journal of hematology.

A comparison of the fungicidal activity of amphotericin B and posaconazole against Zygomycetes in vitro.

G. Alangaden, E. Manavathu, P. Chandrasekar, 2009, Diagnostic microbiology and infectious disease.

Adverse effects of voriconazole: Over a decade of use

P. Chandrasekar, Miriam T. Levine, 2016, Clinical transplantation.

Inhibition of H(+)-ATPase-mediated proton pumping in Cryptococcus neoformans by a novel conjugated styryl ketone.

J. Dimmock, E. Manavathu, P. Chandrasekar, 2001, The Journal of antimicrobial chemotherapy.

Invasive sinusitis and cerebritis due to Curvularia clavata in an immunocompetent adult.

M. Mcginnis, P. Chandrasekar, J. Ebright, 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Efficacy of voriconazole plus amphotericin B or micafungin in a guinea-pig model of invasive pulmonary aspergillosis.

E. Manavathu, J. Cutright, P. Chandrasekar, 2004, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Molecular characterisation of cyp51A and cyp51B genes coding for P450 14alpha-lanosterol demethylases A (CYP51Ap) and B (CYP51Bp) from voriconazole-resistant laboratory isolates of Aspergillus flavus.

G. Alangaden, E. Manavathu, P. Chandrasekar, 2008, International journal of antimicrobial agents.

Treatment of invasive aspergillosis with posaconazole in patients who are refractory to or intolerant of conventional therapy: an externally controlled trial.

J. Perfect, C. White, R. Greene, 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Bone and joint infections in intravenous drug abusers.

P. Chandrasekar, A. Narula, Amrit P. Narula, 1986, Reviews of infectious diseases.

Intravenous and Oral Itraconazole versus Intravenous and Oral Fluconazole for Long-Term Antifungal Prophylaxis in Allogeneic Hematopoietic Stem-Cell Transplant Recipients: A Multicenter, Randomized Trial

M. Territo, H. Lazarus, R. Maziarz, 2003, Annals of Internal Medicine.

Isavuconazole for Treatment of Experimental Fungal Endophthalmitis Caused by Aspergillus fumigatus

P. Singh, P. Chandrasekar, S. Revankar, 2018, Antimicrobial Agents and Chemotherapy.

Management of invasive fungal infections: a role for polyenes.

P. Chandrasekar, 2011, The Journal of antimicrobial chemotherapy.

Sciatic Nerve Damage Associated with Pentamidine

P. Chandrasekar, P. Chandrasekar, L. M. Gutschi, 1985, Drug intelligence & clinical pharmacy.

A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation.

J. L. Goodman, W. Powderly, T. Shea, 1992, The New England journal of medicine.

Aspergillus: rising frequency of clinical isolation and continued susceptibility to antifungal agents, 1994-1999.

E. Manavathu, J. Cutright, P. Chandrasekar, 2001, Diagnostic microbiology and infectious disease.

Fluconazole Prophylaxis of Fungal Infections in Patients with Acute Leukemia: Results of a Randomized Placebo-Controlled, Double-Blind, Multicenter Trial

H. Horowitz, R. Shadduck, C. Rosenfeld, 1993, Annals of Internal Medicine.

Antifungal Drug Resistance in Aspergillus

E. Manavathu, P. Chandrasekar, 2017 .

Successful treatment of primary cutaneous Aspergillus ustus infection with surgical debridement and a combination of voriconazole and terbinafine.

E. Manavathu, P. Chandrasekar, S. Revankar, 2008, Diagnostic microbiology and infectious disease.

Fluvastatin potentiates the activity of caspofungin against Aspergillus fumigatus in vitro.

G. Alangaden, E. Manavathu, P. Chandrasekar, 2008, Diagnostic microbiology and infectious disease.

Efficacy of voriconazole against invasive pulmonary aspergillosis in a guinea-pig model.

E. Manavathu, J. Cutright, P. Chandrasekar, 2000, The Journal of antimicrobial chemotherapy.

Treatment of breakthrough fungal infections: Is there one best drug strategy?

P. Chandrasekar, M. Nailor, 2009 .

Phase 1b Study of New Posaconazole Tablet for Prevention of Invasive Fungal Infections in High-Risk Patients with Neutropenia

J. Perfect, H. Waskin, A. Langston, 2014, Antimicrobial Agents and Chemotherapy.

Differential activity of triazoles in two-drug combinations with the echinocandin caspofungin against Aspergillus fumigatus.

G. Alangaden, E. Manavathu, P. Chandrasekar, 2003, The Journal of antimicrobial chemotherapy.

In vitro susceptibilities of Aspergillus species to voriconazole, itraconazole, and amphotericin B.

E. Manavathu, J. Cutright, P. Chandrasekar, 1999, Diagnostic microbiology and infectious disease.

In-vitro evaluation of cefpirome (HR 810), teicoplanin and four other antimicrobials against enterococci.

D. Levine, P. Chandrasekar, S. Price, 1985, The Journal of antimicrobial chemotherapy.

In vitro-in vivo correlation of voriconazole resistance due to G448S mutation (cyp51A gene) in Aspergillus fumigatus.

J. Cutright, P. Chandrasekar, Wenjuan Wu, 2012, Diagnostic microbiology and infectious disease.

Comparison of the activity of antibiotic combinations in vitro with clinical outcome and resistance emergence in serious infection by Pseudomonas aeruginosa in non-neutropenic patients.

P. Chandrasekar, L. Crane, E. Bailey, 1987, The Journal of antimicrobial chemotherapy.

Enterococcal superinfection and colonization with aztreonam therapy

J. Lefrock, P. Chandrasekar, B. Carr, 1984, Antimicrobial Agents and Chemotherapy.

Comparative study of ceftizoxime and cefamandole in the treatment of bronchopulmonary infections.

R. Schell, J. Lefrock, K. Rolston, 1982, The Journal of antimicrobial chemotherapy.

Infections due to achromobacter xylosoxidans. Case report and review of the literature

D. Levine, P. Chandrasekar, E. Arathoon, 1986, Infection.

False-positive Aspergillus galactomannan (GM) assay in histoplasmosis.

P. Chandrasekar, S. Narreddy, 2008, The Journal of infection.

Oral candidiasis: forerunner of acquired immunodeficiency syndrome (AIDS)?

P. Chandrasekar, P. Chandrasekar, J. A. Molinari, 1985, Oral surgery, oral medicine, and oral pathology.

Therapy with cefoperazone plus sulbactam against disseminated infection due to cefoperazone-resistant Pseudomonas aeruginosa and Escherichia coli in granulocytopenic mice

J. A. Kruse, P. Chandrasekar, J. A. Sluchak, 1993, Antimicrobial Agents and Chemotherapy.

Efficacy and safety of aztreonam in the treatment of serious gram-negative bacterial infections.

J. Lefrock, K. Rolston, P. Chandrasekar, 1987, Archives of internal medicine.

Fungi other than Candida and Aspergillus

P. Chandrasekar, 2003 .

Reduction in False-Positive Aspergillus Serum Galactomannan Enzyme Immunoassay Results Associated with Use of Piperacillin-Tazobactam in the United States

A. Caliendo, S. Norris, J. Baddley, 2014, Journal of Clinical Microbiology.

Efficacy of anidulafungin, caspofungin and fluconazole in the early phase of infection in a neutropenic murine invasive candidiasis model.

E. Manavathu, J. Cutright, P. Chandrasekar, 2010, International journal of antimicrobial agents.

Aspergillus: an increasing problem in tertiary care hospitals?

G. Alangaden, E. Manavathu, P. Chandrasekar, 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

In vitro susceptibility of clinical isolates of Aspergillus fumigatus to conventional and lipid formulations of amphotericin B in 2-drug combination with caspofungin and micafungin

G. Alangaden, E. Manavathu, J. Cutright, 2002 .

Organism-dependent fungicidal activity of azoles

E. Manavathu, P. Chandrasekar, J. L. Outright, 1997 .

Effect of test medium on in vitro susceptibility testing results for Aspergillus fumigatus.

E. Manavathu, P. Chandrasekar, O. C. Abraham, 2000, Revista iberoamericana de micologia.

Nail discoloration and human immunodeficiency virus infection.

P. Chandrasekar, 1989, The American journal of medicine.

In Vivo Resistance of a Laboratory-Selected Aspergillus fumigatus Isolate to Amphotericin B

E. Manavathu, J. Cutright, P. Chandrasekar, 2005, Antimicrobial Agents and Chemotherapy.

Infectious Complications After Umbilical Cord Blood Transplantation for Hematological Malignancy

P. Chandrasekar, S. Revankar, C. Kauffman, 2019, Open forum infectious diseases.

Management of gram-positive bacterial infections in patients with cancer

C. Kosmidis, P. Chandrasekar, 2012, Leukemia & lymphoma.

Antimicrobial tolerance in group C and group G streptococci.

J. Lefrock, K. Rolston, P. Chandrasekar, 1984, The Journal of antimicrobial chemotherapy.

Status Epilepticus due to Severe HHV-6 Encephalitis in an Allogeneic Stem Cell Transplant Recipient

P. Chordia, P. Chandrasekar, 2013, Mediterranean journal of hematology and infectious diseases.

Invasive aspergillosis in patients following umbilical cord blood transplant

P. Chandrasekar, S. Revankar, C. Kauffman, 2019, Bone Marrow Transplantation.

Spiramycin in the Treatment of Cryptosporidiosis

M. Rybak, P. Chandrasekar, A. Pilla, 1987, Pharmacotherapy.

Corynebacterium hemolyticum bacteremia with fatal neurologic complication in an intravenous drug addict.

P. Chandrasekar, J. A. Molinari, 1987, The American journal of medicine.

Carbapenem-Susceptible Klebsiella pneumoniae and Escherichia coli Isolates Carrying a Truncated KPC Carbapenemase: a Challenge for Rapid Molecular Diagnostics

R. Bonomo, A. Hujer, P. Chandrasekar, 2019, Journal of Clinical Microbiology.

1060. Pritelivir in Immunocompromised Patients with Mucocutaneous Acyclovir-Resistant Herpes Simplex Virus-Infections – First Case Series

J. Schiffer, M. Ison, A. Wald, 2021, Open Forum Infectious Diseases.

Randomized comparison of oral valacyclovir and intravenous ganciclovir for prevention of cytomegalovirus disease after allogeneic bone marrow transplantation.

D. Snydman, M. Territo, P. Chandrasekar, 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Alpha-Synuclein Aggregation in Parkinson's Disease

R. Rajasekaran, P. Chandrasekar, R. Karunakaran, 2021, Frontiers in Medicine.

Safety and Efficacy of Cefoperazone Plus Sulbactam versus Ceftazidime in the Empiric Treatment of Febrile Neutropenia

P. Chandrasekar, 1998 .

Cytomegalovirus prophylaxis with valganciclovir in African–American renal allograft recipients based on donor/recipient serostatus

S. Gruber, P. Chandrasekar, G. Alangaden, 2005, Clinical transplantation.

Cefmenoxime. Clinical, bacteriologic, and pharmacologic studies.

R. Schell, J. Lefrock, K. Rolston, 1984, The American journal of medicine.

SARS-CoV-2 infection: Initial viral load (iVL) predicts severity of illness/outcome, and declining trend of iVL in hospitalized patients corresponds with slowing of the pandemic

A. Kanj, P. Chandrasekar, H. Salimnia, 2021, PloS one.

Cefepime versus Ceftazidime as Empiric Therapy for Fever in Neutropenic Patients with Cancer

P. Arnow, P. Chandrasekar, 2000, The Annals of pharmacotherapy.

Bloodstream Infections in Hematologic Malignancy Patients With Fever and Neutropenia: Are Empirical Antibiotic Therapies in the United States Still Effective?

J. Montoya, J. Baddley, T. Walsh, 2022, Open forum infectious diseases.

In-vitro susceptibility of cefoperazone-susceptible and -resistant gram-negative rods to cefoperazone plus sulbactam, other beta-lactams, aminoglycosides and quinolone

P. Chandrasekar, J. A. Sluchak, 1991, Infection.

Baseline Chest Computed Tomography as Standard of Care in High-Risk Hematology Patients

B. Phillips, P. Soler-Palacín, L. Pagano, 2020, Journal of fungi.

Erratum: Effect of zinc supplementation on incidence of infections and hospital admissions in sickle cell disease (SCD) (American Journal of Hematology (1999) 61 (194-202))

F. Beck, P. Swerdlow, J. Fitzgerald, 1999 .

Empirical antifungal therapy for persistent fever in patients with neutropenia.

P. Chandrasekar, 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Quinolone prophylaxis during neutropenia.

P. Chandrasekar, 1991, Annals of Internal Medicine.

Pathogens causing blood stream infections in hospitalized cancer patients, 2000–2001

G. Alangaden, J. Cutright, P. Chandrasekar, 2002 .

Detection of Oseltamivir Resistance during Treatment of 2009 H1N1 Influenza Virus Infection in Immunocompromised Patients: Utility of Cycle Threshold Values of Qualitative Real-Time Reverse Transcriptase PCR

T. Mehta, G. Alangaden, P. Chandrasekar, 2010, Journal of Clinical Microbiology.

Condyloma acuminatum in the oral cavity: four cases and a review.

P. Chandrasekar, R. Plezia, H. Venkat, 1988, Reviews of infectious diseases.

Prophylaxis against Aspergillus is not perfect: problems and perils in stem cell transplantation.

P. Chandrasekar, 2009, Medical mycology.

Hemodynamic responses to Gram‐positive versus Gram‐negative sepsis in critically ill patients with and without circulatory shock

M. Haupt, J. A. Kruse, P. Chandrasekar, 1991, Critical care medicine.

Favorable outcome of COVID‐19 among African American (AA) renal transplant recipients in Detroit

Claudia D. Jarrin Tejada, P. Chandrasekar, M. Zachariah, 2020, Clinical transplantation.

Successful treatment of vancomycin-resistant Enterococcus faecium bacteremia with linezolid after failure of treatment with synercid (quinupristin/dalfopristin).

P. Chandrasekar, C. Kauffman, N. Clark, 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Immune globulin use at a multihospital medical center.

E. Bailey, P. Chandrasekar, P. Brown, 1994, American journal of hospital pharmacy.

Chronic meningitis caused by Listeria in a patient infected with human immunodeficiency virus.

P. Chandrasekar, R. Harvey, 1988, The Journal of infectious diseases.

In Vitro Studies of Exserohilum rostratum with Antifungal Drugs and Methylprednisolone

J. Sobel, P. Chandrasekar, S. Revankar, 2014, Antimicrobial Agents and Chemotherapy.

Hot tub-associated dermatitis due to Pseudomonas aeruginosa. Case report and review of the literature.

J. Lefrock, K. Rolston, P. Chandrasekar, 1984, Archives of dermatology.

Parvovirus B 19 Infection in a Patient with Sickle Cell Crisis

P. Chandrasekar, A. Villanueva, 2022 .

In vitro and in vivo activity of coumermycin and other antibacterial agents against methicillin-resistant strains of Staphylococcus aureus.

D. Levine, J. Unowsky, P. Chandrasekar, 1986, Chemotherapy.

Safety and efficacy of liposomal amphotericin B for the empirical therapy of invasive fungal infections in immunocompromised patients

P. Chandrasekar, M. Miceli, 2012, Infection and drug resistance.

Preliminary Experience With Renal Transplantation in HIV+ Recipients: Low Acute Rejection and Infection Rates

S. Gruber, G. Alangaden, M. Doshi, 2008, Transplantation.

In vitro efficacy of the combination of voriconazole and anidulafungin against voriconazole-resistant cyp51A mutants of Aspergillus fumigatus.

P. Chandrasekar, Wenjuan Wu, S. Krishnan-Natesan, 2012, Diagnostic microbiology and infectious disease.

Fever and eosinophilia associated with voriconazole

P. Chandrasekar, P. Vishnubhotla, R. Ibrahim, 2004, The Annals of pharmacotherapy.

Clinical features and antimicrobial therapy of infections caused by group G streptococci

J. Lefrock, K. Rolston, P. Chandrasekar, 1985, Infection.

Diffusion of ceftriaxone into the cerebrospinal fluid of adults.

J. Lefrock, K. Rolston, P. Chandrasekar, 1984, The Journal of antimicrobial chemotherapy.

Low-back pain and intravenous drug abusers.

P. Chandrasekar, 1990, Archives of internal medicine.

Comparative efficacies of imipenem-cilastatin and vancomycin in experimental aortic valve endocarditis due to methicillin resistant Staphylococcus aureus.

D. Levine, M. Rybak, P. Chandrasekar, 1988, The Journal of antimicrobial chemotherapy.

Letters to the Editor Multidrug-Resistant Trichosporon asahii Isolates Are Susceptible to Voriconazole

R. Rubin, D. Denning, J. Wingard, 2003 .

Polymerase chain reaction in the diagnosis of invasive aspergillosis: approaches for appropriate use

P. Chandrasekar, V. Keri, 2023, Leukemia & lymphoma.

Urgent need for formal medical training in infectious diseases in India.

P. Chandrasekar, 2011, The Lancet. Infectious diseases.

Bandlike erythema over the abdominal wall

P. Chandrasekar, N. Suramaethakul, 2013 .

Safety of posaconazole

P. Jacinto, P. Chandrasekar, 2013, Expert opinion on drug safety.

Cryptococcosis in a febrile renal transplant recipient.

P. Chandrasekar, S. Revankar, 2013, JAMA.

Pre-exposure Prophylaxis in HIV: Is it Time to Act Now?

P. Chandrasekar, N. Nischal, A. Baidya, 2020, Journal of Association of Physicians of India.

Antifungal Resistance: Aspergillus

E. Manavathu, P. Chandrasekar, 2009 .

Drug-Induced Nephrotoxicity Caused by Amphotericin B Lipid Complex and Liposomal Amphotericin B: A Review and Meta-Analysis

J. Wingard, D. Kontoyiannis, T. Walsh, 2010, Medicine.

Infection and Drug Resistance

P. Chandrasekar, M. Miceli, 2022 .

Safety of triazole antifungal drugs in patients with cancer.

P. Chandrasekar, S. Cronin, 2010, The Journal of antimicrobial chemotherapy.

Cutaneous infections due to Acanthamoeba in patients with acquired immunodeficiency syndrome.

P. Chandrasekar, M. Fairfax, L. Crane, 1997, Archives of internal medicine.